CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 80 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $233,000 | -5.3% | 13,400 | -8.2% | 0.04% | -25.0% |
| Q2 2020 | $246,000 | +41.4% | 14,600 | 0.0% | 0.06% | +115.4% |
| Q1 2020 | $174,000 | -1.7% | 14,600 | 0.0% | 0.03% | +30.0% |
| Q4 2019 | $177,000 | -14.1% | 14,600 | 0.0% | 0.02% | -13.0% |
| Q3 2019 | $206,000 | +26.4% | 14,600 | 0.0% | 0.02% | +35.3% |
| Q2 2019 | $163,000 | -4.7% | 14,600 | 0.0% | 0.02% | -22.7% |
| Q1 2019 | $171,000 | -12.3% | 14,600 | 0.0% | 0.02% | -21.4% |
| Q4 2018 | $195,000 | -4.9% | 14,600 | 0.0% | 0.03% | +40.0% |
| Q3 2018 | $205,000 | -10.9% | 14,600 | 0.0% | 0.02% | -31.0% |
| Q2 2018 | $230,000 | -4.2% | 14,600 | 0.0% | 0.03% | -3.3% |
| Q1 2018 | $240,000 | -21.8% | 14,600 | -14.1% | 0.03% | -26.8% |
| Q4 2017 | $307,000 | -11.0% | 17,000 | -5.0% | 0.04% | +2.5% |
| Q3 2017 | $345,000 | +32.7% | 17,900 | -18.6% | 0.04% | +42.9% |
| Q2 2017 | $260,000 | -13.6% | 22,000 | -20.0% | 0.03% | -17.6% |
| Q1 2017 | $301,000 | +17.6% | 27,500 | -21.9% | 0.03% | +13.3% |
| Q4 2016 | $256,000 | -55.2% | 35,200 | -60.0% | 0.03% | -55.2% |
| Q3 2016 | $572,000 | +9.8% | 88,000 | -7.9% | 0.07% | -1.5% |
| Q2 2016 | $521,000 | +15.8% | 95,500 | -0.7% | 0.07% | +21.4% |
| Q1 2016 | $450,000 | -6.1% | 96,200 | 0.0% | 0.06% | -1.8% |
| Q4 2015 | $479,000 | +32.3% | 96,200 | 0.0% | 0.06% | +11.8% |
| Q3 2015 | $362,000 | -37.4% | 96,200 | 0.0% | 0.05% | -38.6% |
| Q2 2015 | $578,000 | +5.3% | 96,200 | -1.8% | 0.08% | -9.8% |
| Q1 2015 | $549,000 | +83.0% | 98,000 | -2.0% | 0.09% | +114.0% |
| Q4 2014 | $300,000 | +11.9% | 100,000 | 0.0% | 0.04% | 0.0% |
| Q3 2014 | $268,000 | -4.3% | 100,000 | 0.0% | 0.04% | -28.3% |
| Q2 2014 | $280,000 | -35.8% | 100,000 | 0.0% | 0.06% | -49.6% |
| Q1 2014 | $436,000 | +35.8% | 100,000 | 0.0% | 0.12% | +2.6% |
| Q4 2013 | $321,000 | +101.9% | 100,000 | 0.0% | 0.12% | +241.2% |
| Q3 2013 | $159,000 | -8.1% | 100,000 | 0.0% | 0.03% | -26.1% |
| Q2 2013 | $173,000 | – | 100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |